These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


603 related items for PubMed ID: 15953796

  • 1. Hypercortisolemia and depression.
    Gillespie CF, Nemeroff CB.
    Psychosom Med; 2005; 67 Suppl 1():S26-8. PubMed ID: 15953796
    [Abstract] [Full Text] [Related]

  • 2. The hypothalamic-pituitary-adrenal axis in depression.
    Meltzer HY, Lowy MT, Koenig JI.
    Adv Biochem Psychopharmacol; 1987; 43():165-82. PubMed ID: 3035885
    [No Abstract] [Full Text] [Related]

  • 3. Impaired hypothalamic-pituitary-adrenocortical (HPA) system is related to severity of benzodiazepine withdrawal in patients with depression.
    Wichniak A, Brunner H, Ising M, Pedrosa Gil F, Holsboer F, Friess E.
    Psychoneuroendocrinology; 2004 Oct; 29(9):1101-8. PubMed ID: 15219633
    [Abstract] [Full Text] [Related]

  • 4. Depression and endocrine disorders: focus on the thyroid and adrenal system.
    Musselman DL, Nemeroff CB.
    Br J Psychiatry Suppl; 1996 Jun; (30):123-8. PubMed ID: 8864158
    [Abstract] [Full Text] [Related]

  • 5. [Limbic-hypothalamic-pituitary-adrenal axis in depression: literature review].
    Twardowska K, Rybakowski J.
    Psychiatr Pol; 1996 Jun; 30(5):741-55. PubMed ID: 8984515
    [Abstract] [Full Text] [Related]

  • 6. Do anxiety and depression have a common pathophysiological mechanism?
    Boyer P.
    Acta Psychiatr Scand Suppl; 2000 Jun; (406):24-9. PubMed ID: 11131467
    [Abstract] [Full Text] [Related]

  • 7. Anna-Monika-Prize paper. The hypothalamic-pituitary-adrenal system in depression.
    Heuser I.
    Pharmacopsychiatry; 1998 Jan; 31(1):10-3. PubMed ID: 9524978
    [Abstract] [Full Text] [Related]

  • 8. Hypothalamic-pituitary-adrenal axis and immune system.
    Savastano S, Tommaselli AP, Valentino R, Scarpitta MT, D'Amore G, Luciano A, Covelli V, Lombardi G.
    Acta Neurol (Napoli); 1994 Aug; 16(4):206-13. PubMed ID: 7856475
    [Abstract] [Full Text] [Related]

  • 9. An investigation of hypothalamic-pituitary-adrenal axis hyperactivity in anorexia nervosa: the role of CRH and AVP.
    Connan F, Lightman SL, Landau S, Wheeler M, Treasure J, Campbell IC.
    J Psychiatr Res; 2007 Aug; 41(1-2):131-43. PubMed ID: 16455105
    [Abstract] [Full Text] [Related]

  • 10. The dex/CRH test--is it better than the DST?
    Watson S, Gallagher P, Smith MS, Ferrier IN, Young AH.
    Psychoneuroendocrinology; 2006 Aug; 31(7):889-94. PubMed ID: 16701957
    [Abstract] [Full Text] [Related]

  • 11. Changes in hypothalamic-pituitary-adrenal axis measures after vagus nerve stimulation therapy in chronic depression.
    O'Keane V, Dinan TG, Scott L, Corcoran C.
    Biol Psychiatry; 2005 Dec 15; 58(12):963-8. PubMed ID: 16005439
    [Abstract] [Full Text] [Related]

  • 12. Depression and hypothalamic-pituitary-adrenal activation: a quantitative summary of four decades of research.
    Stetler C, Miller GE.
    Psychosom Med; 2011 Dec 15; 73(2):114-26. PubMed ID: 21257974
    [Abstract] [Full Text] [Related]

  • 13. Clinical significance of psychoneuroendocrinology in psychiatry: focus on the thyroid and adrenal.
    Nemeroff CB.
    J Clin Psychiatry; 1989 May 15; 50 Suppl():13-20; discussion 21-2. PubMed ID: 2654128
    [Abstract] [Full Text] [Related]

  • 14. Longitudinal neuroendocrine changes assessed by dexamethasone/CRH and growth hormone releasing hormone tests in psychotic depression.
    Owashi T, Otsubo T, Oshima A, Nakagome K, Higuchi T, Kamijima K.
    Psychoneuroendocrinology; 2008 Feb 15; 33(2):152-61. PubMed ID: 18068306
    [Abstract] [Full Text] [Related]

  • 15. [Pseudo-Cushing syndrome. Physiopathologic aspects and differential diagnosis].
    Ceroni L, Cota D, Pasquali R.
    Minerva Endocrinol; 2000 Jun 15; 25(2):47-54. PubMed ID: 11189791
    [Abstract] [Full Text] [Related]

  • 16. Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs low CRH/NE states.
    Gold PW, Chrousos GP.
    Mol Psychiatry; 2002 Jun 15; 7(3):254-75. PubMed ID: 11920153
    [Abstract] [Full Text] [Related]

  • 17. Psychiatric implications of basic and clinical studies with corticotropin-releasing factor.
    Gold PW, Chrousos G, Kellner C, Post R, Roy A, Augerinos P, Schulte H, Oldfield E, Loriaux DL.
    Am J Psychiatry; 1984 May 15; 141(5):619-27. PubMed ID: 6324597
    [Abstract] [Full Text] [Related]

  • 18. The neurobiological basis of mixed depression-anxiety states.
    Gulley LR, Nemeroff CB.
    J Clin Psychiatry; 1993 Jan 15; 54 Suppl():16-9. PubMed ID: 8093884
    [Abstract] [Full Text] [Related]

  • 19. Hypothalamus-pituitary-adrenal (HPA) axis in physiological and pathological aging brain.
    Lombardi G, Merola B, Savastano S, Tommaselli AP, Valentino R, Rossi R, Ghiggi MR, Cataldi M.
    Acta Neurol (Napoli); 1991 Aug 15; 13(4):368-73. PubMed ID: 1781312
    [No Abstract] [Full Text] [Related]

  • 20. Association of IL-6, hypothalamus-pituitary-adrenal axis function, and depression in patients with cancer.
    Jehn CF, Kühnhardt D, Bartholomae A, Pfeiffer S, Schmid P, Possinger K, Flath BC, Lüftner D.
    Integr Cancer Ther; 2010 Sep 15; 9(3):270-5. PubMed ID: 20702499
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 31.